• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical experience with pefloxacin in the therapy of typhoid fever.

作者信息

Cristiano P, Morelli G, Briante V, Iovene M R, Simioli F, Altucci P

机构信息

Institute of Internal Medicine 1st Medical School, Naples University, Italy.

出版信息

Infection. 1989 Mar-Apr;17(2):86-7. doi: 10.1007/BF01646882.

DOI:10.1007/BF01646882
PMID:2714862
Abstract

Thirty hospitalized patients (22 men and eight women), aged between 15 and 41 years (mean = 25.4 years), with severe proven typhoid sepsis were treated with pefloxacin at daily dose of 1200 mg, divided in three doses, intravenously for the first five days and orally for the following ten days of treatment. All patients completely recovered from infection and pathogens were eradicated after 30 days of follow-up. In none of the patients was a relapse registered during the follow-up or enteric carrier state after disease. Pefloxacin therapy was well tolerated by all patients: in five patients a mild and transient epigastric pain and in one patient a mild and transient nausea were registered. Pefloxacin is a safe and effective agent for therapy of typhoid fever.

摘要

相似文献

1
Clinical experience with pefloxacin in the therapy of typhoid fever.
Infection. 1989 Mar-Apr;17(2):86-7. doi: 10.1007/BF01646882.
2
Pefloxacin versus chloramphenicol in the therapy of typhoid fever.
Infection. 1995 Mar-Apr;23(2):103-6. doi: 10.1007/BF01833875.
3
The efficacy and safety of pefloxacin in the treatment of typhoid fever in Algeria.培氟沙星治疗阿尔及利亚伤寒热的疗效与安全性。
J Antimicrob Chemother. 1990 Oct;26 Suppl B:181-6. doi: 10.1093/jac/26.suppl_b.181.
4
[Eradication of asymptomatic carrier state of non-typhoid Salmonella with two doses of pefloxacin].[两剂培氟沙星根除非伤寒沙门氏菌无症状携带状态]
Arch Pediatr. 1995 May;2(5):418-22. doi: 10.1016/0929-693x(96)81175-4.
5
Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients.
J Antimicrob Chemother. 1990 Oct;26 Suppl B:193-8. doi: 10.1093/jac/26.suppl_b.193.
6
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.培氟沙星与复方新诺明治疗成人伤寒前瞻性随机对照试验
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):361-3. doi: 10.1007/BF01962337.
7
Effects of pefloxacin in multi drug resistant typhoid Fever.
Pak J Pharm Sci. 2005 Oct;18(4):61-4.
8
Monotherapy with pefloxacin in multidrug-resistant nosocomial gram-negative bacteraemia.培氟沙星单药治疗多重耐药医院获得性革兰阴性菌血症
J Antimicrob Chemother. 1990 Oct;26 Suppl B:91-5. doi: 10.1093/jac/26.suppl_b.91.
9
Effects of pefloxacin in multi drug resistant typhoid fever.培氟沙星对多重耐药伤寒热的作用
Pak J Pharm Sci. 2006 Jan;19(1):85.
10
Eradication of convalescent-phase Salmonella carriage in children with two oral doses of pefloxacin.两剂口服培氟沙星根除儿童恢复期沙门氏菌携带状态
Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):307-10. doi: 10.1007/BF01974606.

引用本文的文献

1
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.侵袭性沙门氏菌感染的流行病学、临床表现、实验室诊断、抗菌药物耐药性及抗菌药物管理
Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15.
2
Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.氟喹诺酮类药物:运用临床数据通过客观判断分析(SOJA)方法辅助处方选择
Pharmacoeconomics. 1994 Jul;6(1):15-33. doi: 10.2165/00019053-199406010-00003.
3
Pefloxacin versus chloramphenicol in the therapy of typhoid fever.

本文引用的文献

1
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.甲磺酸培氟沙星在小鼠、大鼠、犬、猴及人体内的吸收、分布、代谢转归及消除
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463.
2
Salmonella typhi in vivo acquires resistance to both chloramphenicol and co-trimoxazole.伤寒沙门氏菌在体内对氯霉素和复方新诺明均产生耐药性。
Lancet. 1981 May 30;1(8231):1181-3. doi: 10.1016/s0140-6736(81)92350-3.
3
Antibiotic susceptibility testing by a standardized single disk method.
Infection. 1995 Mar-Apr;23(2):103-6. doi: 10.1007/BF01833875.
4
Fluoroquinolones in the treatment of typhoid fever and the carrier state.氟喹诺酮类药物治疗伤寒及带菌状态。
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):334-41. doi: 10.1007/BF01967008.
采用标准化单纸片法进行抗生素敏感性试验。
Am J Clin Pathol. 1966 Apr;45(4):493-6.
4
Transferable chloramphenicol resistance in Salmonella typhi.伤寒沙门氏菌中可转移的氯霉素耐药性。
Nature. 1972 Sep 8;239(5367):109-10. doi: 10.1038/239109b0.
5
Antibiotic sensitivity testing. Report of an international collaborative study.抗生素敏感性试验。一项国际合作研究报告。
Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217:Suppl 217:1+.
6
Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor.越南与R因子相关的耐氯霉素伤寒热
Lancet. 1973 Nov 3;302(7836):983-5. doi: 10.1016/s0140-6736(73)91086-6.
7
[Pharmacokinetic behavior of pefloxacin in man].培氟沙星在人体中的药代动力学行为
Rev Med Interne. 1986 Mar;7(2):185-95. doi: 10.1016/s0248-8663(86)80113-8.
8
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.培氟沙星与依诺沙星、诺氟沙星、庆大霉素及新型β-内酰胺类药物的体外活性比较。
J Antimicrob Chemother. 1985 Jan;15(1):39-44. doi: 10.1093/jac/15.1.39.
9
In-vitro activity of pefloxacin compared to other antibiotics.培氟沙星与其他抗生素相比的体外活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:19-28. doi: 10.1093/jac/17.suppl_b.19.
10
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
J Antimicrob Chemother. 1986 Apr;17 Suppl B:11-7. doi: 10.1093/jac/17.suppl_b.11.